Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $168 - $191
-4 Reduced -0.0%
414,952 $18.1 Million
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $138,632 - $164,512
-3,446 Reduced 0.82%
414,956 $18.1 Million
Q4 2021

Feb 14, 2022

SELL
$38.88 - $45.31 $109,252 - $127,321
-2,810 Reduced 0.67%
418,402 $18.5 Million
Q3 2021

Nov 15, 2021

SELL
$38.79 - $43.16 $1.7 Million - $1.89 Million
-43,850 Reduced 9.43%
421,212 $16.1 Million
Q2 2021

Aug 16, 2021

SELL
$36.52 - $41.46 $142,428 - $161,694
-3,900 Reduced 0.83%
465,062 $18.5 Million
Q1 2021

May 17, 2021

SELL
$34.27 - $40.01 $39,067 - $45,611
-1,140 Reduced 0.24%
468,962 $16.7 Million
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $2.23 Million - $2.61 Million
-65,372 Reduced 12.21%
470,102 $17.3 Million
Q3 2020

Nov 16, 2020

SELL
$38.11 - $42.99 $22,408 - $25,278
-588 Reduced 0.11%
535,474 $20.2 Million
Q1 2020

May 15, 2020

SELL
$32.47 - $48.83 $87,669 - $131,841
-2,700 Reduced 0.5%
536,062 $20.3 Million
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $403,200 - $463,200
-9,600 Reduced 1.75%
538,762 $25.3 Million
Q2 2019

Aug 14, 2019

SELL
$39.4 - $42.7 $57,366 - $62,171
-1,456 Reduced 0.26%
548,362 $21.9 Million
Q1 2019

May 15, 2019

SELL
$38.57 - $42.69 $5,515 - $6,104
-143 Reduced 0.03%
549,818 $23 Million
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $1.96 Million - $2.21 Million
-51,738 Reduced 8.6%
549,961 $21 Million
Q3 2018

Nov 14, 2018

SELL
$39.75 - $42.69 $2.12 Million - $2.27 Million
-53,238 Reduced 8.13%
601,699 $24.2 Million
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $28,677 - $30,958
724 Added 0.11%
654,937 $26.4 Million
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $3,618 - $4,015
100 Added 0.02%
654,213 $25.6 Million
Q4 2017

Feb 14, 2018

SELL
$35.34 - $41.9 $397,893 - $471,752
-11,259 Reduced 1.69%
654,113 $23.2 Million
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $26.2 Million - $27.6 Million
665,372
665,372 $27 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.